Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics.

Hines KM, Waalkes A, Penewit K, Holmes EA, Salipante SJ, Werth BJ, Xu L.

mSphere. 2017 Dec 13;2(6). pii: e00492-17. doi: 10.1128/mSphere.00492-17. eCollection 2017 Nov-Dec.

2.

Enterococci and Their Interactions with the Intestinal Microbiome.

Dubin K, Pamer EG.

Microbiol Spectr. 2014 Nov;5(6). doi: 10.1128/microbiolspec.BAD-0014-2016.

3.

Enterococcus faecalis Responds to Individual Exogenous Fatty Acids Independently of Their Degree of Saturation or Chain Length.

Saito HE, Harp JR, Fozo EM.

Appl Environ Microbiol. 2017 Dec 15;84(1). pii: e01633-17. doi: 10.1128/AEM.01633-17. Print 2018 Jan 1.

4.

Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure.

Bhardwaj P, Hans A, Ruikar K, Guan Z, Palmer KL.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01235-17. doi: 10.1128/AAC.01235-17. Print 2018 Jan.

5.

Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Infection.

Belley A, Lalonde-S├ęguin D, Arhin FF, Moeck G.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01265-17. doi: 10.1128/AAC.01265-17. Print 2017 Oct.

PMID:
28784674
6.

Molecular State of the Membrane-Active Antibiotic Daptomycin.

Lee MT, Hung WC, Hsieh MH, Chen H, Chang YY, Huang HW.

Biophys J. 2017 Jul 11;113(1):82-90. doi: 10.1016/j.bpj.2017.05.025.

PMID:
28700928
7.

Antimicrobial resistance status of Enterococcus from Australian cattle populations at slaughter.

Barlow RS, McMillan KE, Duffy LL, Fegan N, Jordan D, Mellor GE.

PLoS One. 2017 May 18;12(5):e0177728. doi: 10.1371/journal.pone.0177728. eCollection 2017.

8.

Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis.

Rashid R, Cazenave-Gassiot A, Gao IH, Nair ZJ, Kumar JK, Gao L, Kline KA, Wenk MR.

PLoS One. 2017 Apr 19;12(4):e0175886. doi: 10.1371/journal.pone.0175886. eCollection 2017.

9.

Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.

Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Proctor R, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02435-16. doi: 10.1128/AAC.02435-16. Print 2017 Apr.

10.

A Novel Phosphodiesterase of the GdpP Family Modulates Cyclic di-AMP Levels in Response to Cell Membrane Stress in Daptomycin-Resistant Enterococci.

Wang X, Davlieva M, Reyes J, Panesso D, Arias CA, Shamoo Y.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01422-16. doi: 10.1128/AAC.01422-16. Print 2017 Mar.

11.

Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.

DiPippo AJ, Tverdek FP, Tarrand JJ, Munita JM, Tran TT, Arias CA, Shelburne SA, Aitken SL.

J Infect. 2017 Mar;74(3):243-247. doi: 10.1016/j.jinf.2016.11.004. Epub 2016 Nov 11.

PMID:
27845153
14.

Antimicrobial Peptides Targeting Gram-Positive Bacteria.

Malanovic N, Lohner K.

Pharmaceuticals (Basel). 2016 Sep 20;9(3). pii: E59. doi: 10.3390/ph9030059. Review.

15.

Strain Dependent Genetic Networks for Antibiotic-Sensitivity in a Bacterial Pathogen with a Large Pan-Genome.

van Opijnen T, Dedrick S, Bento J.

PLoS Pathog. 2016 Sep 8;12(9):e1005869. doi: 10.1371/journal.ppat.1005869. eCollection 2016 Sep.

16.

Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Miller WR, Bayer AS, Arias CA.

Cold Spring Harb Perspect Med. 2016 Nov 1;6(11). pii: a026997. doi: 10.1101/cshperspect.a026997. Review.

17.

Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.

Duerkop BA, Huo W, Bhardwaj P, Palmer KL, Hooper LV.

MBio. 2016 Aug 30;7(4). pii: e01304-16. doi: 10.1128/mBio.01304-16.

18.
19.

Targeting cell membrane adaptation as a novel antimicrobial strategy.

Tran TT, Miller WR, Shamoo Y, Arias CA.

Curr Opin Microbiol. 2016 Oct;33:91-96. doi: 10.1016/j.mib.2016.07.002. Epub 2016 Jul 25. Review.

20.

Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.

Hall Snyder AD, Werth BJ, Nonejuie P, McRoberts JP, Pogliano J, Sakoulas G, Yim J, Singh N, Rybak MJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5716-23. doi: 10.1128/AAC.00687-16. Print 2016 Oct.

Supplemental Content

Support Center